Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2014
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Eleni Avtzi, Frederik L Giesel, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 3, 2017
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imagingSara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 28, 2019
Comparison of PSMA-ligand PET/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvisAli Afshar-Oromieh, Bernd Vollnberg, Ian Alberts, et al.Theranostics|July 1, 2024
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?Alina T Küper, David Kersting, Tugce Telli, et al.Swiss Medical Weekly|January 21, 2025
Advancements in lung cancer: a comprehensive perspective on diagnosis, staging, therapy and follow-up from the SAKK Working Group on Imaging in Diagnosis and Therapy MonitoringLisa Jungblut, Stefania Maria Rizzo, Lukas Ebner, et al.Theriogenology|September 12, 2023
Alpha-linolenic acid alleviates the detrimental effects of lipopolysaccharide during in vitro ovine oocyte developmentSara Ataei-Nazari, Amin Rahimi, Mohammad Reza Bakhtiarizadeh, et al.World Journal of Urology|June 14, 2019
68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy studyLars J Petersen, Julie B Nielsen, Niels C Langkilde, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PETAndrea Farolfi, Harun Ilhan, Andrei Gafita, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2017
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patientsAli Afshar-Oromieh, Tim Holland-Letz, Frederik L Giesel, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2018
Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancerHelle D Zacho, Julie B Nielsen, Ali Afshar-Oromieh, et al.Pageof 15